199 related articles for article (PubMed ID: 10024074)
21. In the absence of counterregulatory hormones, the increase in hepatic glucose production during insulin-induced hypoglycemia in the dog is initiated in the liver rather than the brain.
Connolly CC; Myers SR; Neal DW; Hastings JR; Cherrington AD
Diabetes; 1996 Dec; 45(12):1805-13. PubMed ID: 8922369
[TBL] [Abstract][Full Text] [Related]
22. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
Rebrin K; Steil GM; Mittelman SD; Bergman RN
J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866
[TBL] [Abstract][Full Text] [Related]
23. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
[TBL] [Abstract][Full Text] [Related]
24. Direct and indirect effects of insulin on glucose uptake and storage by the liver.
Satake S; Moore MC; Igawa K; Converse M; Farmer B; Neal DW; Cherrington AD
Diabetes; 2002 Jun; 51(6):1663-71. PubMed ID: 12031951
[TBL] [Abstract][Full Text] [Related]
25. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
Shiota M; Galassetti P; Monohan M; Neal DW; Cherrington AD
Diabetes; 1998 Jun; 47(6):867-73. PubMed ID: 9604861
[TBL] [Abstract][Full Text] [Related]
26. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
[TBL] [Abstract][Full Text] [Related]
27. Hepatic extraction of exogenous insulin in depancreatized conscious dogs.
Ishida T; Chap Z; Chou J; Lewis RM; Hartley CJ; Entman ML; Field JB
Am J Physiol; 1984 Apr; 246(4 Pt 1):E369-79. PubMed ID: 6372507
[TBL] [Abstract][Full Text] [Related]
28. The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs.
Matsuhisa M; Shi ZQ; Wan C; Lekas M; Rodgers CD; Giacca A; Kawamori R; Vranic M
Diabetes; 1997 Feb; 46(2):224-31. PubMed ID: 9000698
[TBL] [Abstract][Full Text] [Related]
29. Interaction of insulin and prior exercise in control of hepatic metabolism of a glucose load.
Pencek RR; James F; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
Diabetes; 2003 Aug; 52(8):1897-903. PubMed ID: 12882903
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
31. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
[TBL] [Abstract][Full Text] [Related]
32. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
[TBL] [Abstract][Full Text] [Related]
33. Hepatic and muscle insulin action during late pregnancy in the dog.
Connolly CC; Papa T; Smith MS; Lacy DB; Williams PE; Moore MC
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R447-52. PubMed ID: 16973936
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I and insulin have no differential effects on glucose production and utilization under conditions of hyperglycemia.
Giacca A; Fisher SJ; Shi ZQ; Gupta R; Lickley HL; Skottner A; Anderson GH; Efendic S; Vranic M
Endocrinology; 1994 May; 134(5):2251-8. PubMed ID: 8156929
[TBL] [Abstract][Full Text] [Related]
35. Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog.
Sindelar DK; Chu CA; Neal DW; Cherrington AD
Am J Physiol; 1997 Nov; 273(5):E972-80. PubMed ID: 9374684
[TBL] [Abstract][Full Text] [Related]
36. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.
Hawkins M; Gabriely I; Wozniak R; Reddy K; Rossetti L; Shamoon H
Diabetes; 2002 Jul; 51(7):2179-89. PubMed ID: 12086948
[TBL] [Abstract][Full Text] [Related]
37. Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.
Stevenson RW; Orskov H; Parsons JA; Alberti KG
Am J Physiol; 1983 Aug; 245(2):E200-8. PubMed ID: 6349384
[TBL] [Abstract][Full Text] [Related]
38. Determinants of glucose turnover in the pathophysiology of diabetes: an in vivo analysis in diabetic dogs.
Fisher SJ; Lekas MC; McCall RH; Shi ZQ; Giacca A; Vranic M
Diabetes Metab; 1996 Apr; 22(2):111-21. PubMed ID: 8792091
[TBL] [Abstract][Full Text] [Related]
39. Increased urea synthesis in insulin-dependent diabetic dogs maintained normoglycemic: effect of portal insulin administration and food protein content.
Freyse EJ; Rebrin K; Schneider T; Petrzika M; Fischer U
Diabetes; 1996 May; 45(5):667-74. PubMed ID: 8621020
[TBL] [Abstract][Full Text] [Related]
40. Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog.
Stevenson RW; Williams PE; Cherrington AD
Diabetologia; 1987 Oct; 30(10):782-90. PubMed ID: 3322904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
